When the US Centers for Disease Control and Prevention (CDC) relaxed its mask guidance in May, the news caught many people—especially corporate America—off guard.
In this Forbesarticle, McDermott partner Michael W. Peregrine argues that companies need to provide stakeholders with clear health and safety messaging in light of mandates from state and local governments.
“Companies can ill-afford to drift in the wind of confusion and controversy, and they can’t be blindsided by further guidance change should there be an increase in reported cases or should variants, like those first found in India, surface in the United States,” Peregrine writes.
As the telemedicine regulatory and reimbursement environment becomes more cohesive and providers and patients alike embrace technology, opportunities for telemedicine collaborations are likely to grow. Like any collaboration, finding the right partner is crucial for success, particularly at the highly scrutinized intersection of healthcare and technology. This post explores the factors to address when evaluating service providers and vendors for your next telemedicine collaboration.